IMAB
I-Mab
NASDAQ · Healthcare · Biotechnology · US
$2.88
−0.69%Aug 20, 2026, 11:00 UTC
NovaBridge Biosciences reported financial results for the six months ended June 30, 2026, and provided a business update on pipeline momentum and strategic execution.